In contrast to IL-17F, IL-17A induced weak to no activation of the canonical pNFkBp105 pathway in either population of T cells (CD4−CD3+ and CD4+CD3+) in CLL and healthy donor samples. Here, IL17F is linked to B-cell chronic lymphocytic leukemia.